The Board will consider and transact the following businesses:
1. Alteration of the Main Object Clause of the Memorandum of Association of the Company, subject to approval of Members and other statutory/regulatory approvals
2. Evaluation of proposal for raising funds to augment financial resources through issue and allotment of Equity Shares, Convertible Equity Warrants and/or any other securities, or through other permissible modes, subject to applicable statutory and regulatory approvals including Member approval
3. Change of name of the Company, subject to approval of Members and other statutory/regulatory approvals
4. Alteration of Memorandum of Association and Articles of Association consequential to the proposed changes, subject to Member approval and other required approvals
5. Formation/incorporation of a subsidiary in the United Arab Emirates (UAE), subject to applicable laws and regulatory requirements
6. Acquisition of stake in an unlisted company utilizing the funds raised by the Company, subject to requisite approvals of Members, Stock Exchange(s), and other regulatory authorities
7. Convening an Extra-Ordinary General Meeting (EGM) of Members for seeking approval for the aforesaid matters and other necessary matters
8. Appointment of a Scrutinizer for conducting the voting process at the proposed EGM as required under applicable law provisions
9. Any other business with permission of the Chairperson
In accordance with SEBI LODR Regulations and the Company's Code of Conduct, the Trading Window for dealing in the Company's securities shall remain closed for all Insiders, including Designated Persons, their immediate relatives and all other covered persons. The closure is effective from October 16, 2026, and shall reopen after the expiry of the prescribed period following the conclusion of the Board Meeting.